Mozambique: Prohibitive Cost of Anti-Retrovirals

Mozambique's health minister on Wednesday stressed the difficulty African countries faced in meeting the cost of anti-retrovirals. Francisco Songane said in parliament that the prices charged by the major western pharmaceutical companies were "immoral", PANA reported. Standard triple therapy costs US $12,000 per patient per year. "If we had to import these drugs, given the number of infected people in Mozambique, we would spend eight billion dollars a year." Even generic drugs from India or Brazil would be beyond the reach of most Mozambicans, he added, but suggested the problem could be dealt with through subsidies, or by employers contributing to the cost of drugs.

AllAfrica publishes around 800 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.